Cardiology

Higher risks without cardio benefits halt study of aleglitazar

The phase III AleCardio trial was ended early when patients with type 2 diabetes and recent acute coronary syndrome who were treated with aleglitazar showed higher rates of heart failure, kidney events and gastrointestinal ...

Cardiology

Short bursts of exercise may cut heart disease risk

(Medical Xpress)—A University of Queensland study has found high-intensity short-duration exercise provides better results than the recommended 30 minutes of daily exercise.

page 36 from 40